IO Biotech (IOBT) Projected to Post Earnings on Tuesday

IO Biotech (NASDAQ:IOBT - Get Free Report) will likely be releasing its earnings data on Tuesday, March 4th. Analysts expect IO Biotech to post earnings of ($0.39) per share for the quarter.

IO Biotech Trading Down 5.4 %

NASDAQ:IOBT traded down $0.05 during trading hours on Friday, reaching $0.95. 135,213 shares of the company traded hands, compared to its average volume of 137,964. The business's 50-day moving average price is $0.92 and its two-hundred day moving average price is $1.03. IO Biotech has a 1 year low of $0.66 and a 1 year high of $1.85. The stock has a market capitalization of $62.26 million, a P/E ratio of -0.69 and a beta of 0.24.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a "buy" rating and issued a $12.00 price target on shares of IO Biotech in a research note on Tuesday, November 12th.

IO Biotech Company Profile

IO Biotech, Inc, a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer.